![Mark Noel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Noel
Geen lopende functies
Profiel
Mr. Mark W.
Noel was previously employed as a VP-Technology Management & Intellectual Property by Curis, Inc., a Vice President-Customer Relations by Gene Logic, Inc., a Deputy Director by National Cancer Institute, and a Director-Regulatory Affairs Department by Gist-Brocades NV.
He received his undergraduate degree from the University of Maryland.
Eerdere bekende functies van Mark Noel
| Bedrijven | Functie | Einde |
|---|---|---|
| CURIS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-05-2026 |
Gene Logic, Inc.
 Gene Logic, Inc. BiotechnologyHealth Technology Develops and discovers pharmaceutical | Corporate Officer/Principal | 01-02-2001 |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Corporate Officer/Principal | 01-01-1998 |
Gist-Brocades NV | Algemeen Adviseur | - |
Opleiding van Mark Noel
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
55
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Gene Logic, Inc.
Gene Logic, Inc. BiotechnologyHealth Technology Develops and discovers pharmaceutical | Health Technology |
Curis, Inc.
 Curis, Inc. BiotechnologyHealth Technology Develops therapeutics to treat cancer | Health Technology |
University of Maryland
 University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Miscellaneous |
Gist-Brocades NV |
